Sym-004 Offers Hope for EGFR Wild Type Lung Cancer Patients
Article
Eighty percent of lung cancer patients have wild type EGFR, meaning there is no EGFR mutation. Dr. Joan Schiller of UT Southwestern Medical Center discusses a new drug in development that may help those patients. February 2014
[powerpress]